TIL + pembro regimen achieves 24% response rate in solid epithelial tumors, marking a step forward in immunotherapy research April 18, 2025Vol.51 No.15By Jacquelyn Cobb
Only half of adolescents and young adults with cancer get fertility counseling before treatmentOncofertility consult is an oft-overlooked standard of care April 11, 2025Vol.51 No.14By Claire Marie Porter
Survey reveals most Americans are uninformed about HPVA vaccine can prevent cancer—most people don’t take it March 07, 2025Vol.51 No.09By Claire Marie Porter
FreeTrials & Tribulations The new therapeutic imperative in cancer management: Sequence, biosimulate, treat March 07, 2025Vol.51 No.09By Michael P. Castro
Trials & Tribulations LLS former CSO: Immunotherapy, precision medicine redefined blood cancer treatment February 07, 2025Vol.51 No.05By Lee Greenberger
Trials & Tribulations Physicians and biopharma should improve accessibility of cancer trials February 07, 2025Vol.51 No.05By Michel van Harten
Trials & Tribulations From clinician scientist to nonprofit CEO January 24, 2025Vol.51 No.03By E. Anders Kolb
NCCN publishes patient resource on genetic testing to guide patient decisionmaking January 17, 2025Vol.51 No.02By Jacquelyn Cobb
Trials & Tribulations Chadi Nabhan: Why I wrote a book about cancer January 17, 2025Vol.51 No.02By Chadi Nabhan
FreeTrials & Tribulations New colorectal cancer screening strategies must advance the standard of care January 10, 2025Vol.51 No.01By Paul J. Limburg
